Cavin‐2 promotes fibroblast‐to‐myofibroblast trans‐differentiation and aggravates cardiac fibrosis
Abstract Aims Transforming growth factor β (TGF‐β) signalling is one of the critical pathways in fibroblast activation, and several drugs targeting the TGF‐β/Smad signalling pathway in heart failure with cardiac fibrosis are being tested in clinical trials. Some caveolins and cavins, which are compo...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-02-01
|
| Series: | ESC Heart Failure |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ehf2.14571 |
| _version_ | 1797348404576124928 |
|---|---|
| author | Yusuke Higuchi Takehiro Ogata Naohiko Nakanishi Masahiro Nishi Yumika Tsuji Shinya Tomita Simon J. Conway Satoaki Matoba |
| author_facet | Yusuke Higuchi Takehiro Ogata Naohiko Nakanishi Masahiro Nishi Yumika Tsuji Shinya Tomita Simon J. Conway Satoaki Matoba |
| author_sort | Yusuke Higuchi |
| collection | DOAJ |
| description | Abstract Aims Transforming growth factor β (TGF‐β) signalling is one of the critical pathways in fibroblast activation, and several drugs targeting the TGF‐β/Smad signalling pathway in heart failure with cardiac fibrosis are being tested in clinical trials. Some caveolins and cavins, which are components of caveolae on the plasma membrane, are known for their association with the regulation of TGF‐β signalling. Cavin‐2 is particularly abundant in fibroblasts; however, the detailed association between Cavin‐2 and cardiac fibrosis is still unclear. We tried to clarify the involvement and role of Cavin‐2 in fibroblasts and cardiac fibrosis. Methods and results To clarify the role of Cavin‐2 in cardiac fibrosis, we performed transverse aortic constriction (TAC) operations on four types of mice: wild‐type (WT), Cavin‐2 null (Cavin‐2 KO), Cavin‐2flox/flox, and activated fibroblast‐specific Cavin‐2 conditional knockout (Postn‐Cre/Cavin‐2flox/flox, Cavin‐2 cKO) mice. We collected mouse embryonic fibroblasts (MEFs) from WT and Cavin‐2 KO mice and investigated the effect of Cavin‐2 in fibroblast trans‐differentiation into myofibroblasts and associated TGF‐β signalling. Four weeks after TAC, cardiac fibrotic areas in both the Cavin‐2 KO and the Cavin‐2 cKO mice were significantly decreased compared with each control group (WT 8.04 ± 1.58% vs. Cavin‐2 KO 0.40 ± 0.03%, P < 0.01; Cavin‐2flox/flox, 7.19 ± 0.50% vs. Cavin‐2 cKO 0.88 ± 0.44%, P < 0.01). Fibrosis‐associated mRNA expression (Col1a1, Ctgf, and Col3) was significantly attenuated in the Cavin‐2 KO mice after TAC. α1 type I collagen deposition and non‐vascular αSMA‐positive cells (WT 43.5 ± 2.4% vs. Cavin‐2 KO 25.4 ± 3.2%, P < 0.01) were reduced in the heart of the Cavin‐2 cKO mice after TAC operation. The levels of αSMA protein (0.36‐fold, P < 0.05) and fibrosis‐associated mRNA expression (Col1a1, 0.69‐fold, P < 0.01; Ctgf, 0.27‐fold, P < 0.01; Col3, 0.60‐fold, P < 0.01) were decreased in the Cavin‐2 KO MEFs compared with the WT MEFs. On the other hand, αSMA protein levels were higher in the Cavin‐2 overexpressed MEFs compared with the control MEFs (2.40‐fold, P < 0.01). TGF‐β1‐induced Smad2 phosphorylation was attenuated in the Cavin‐2 KO MEFs compared with WT MEFs (0.60‐fold, P < 0.01). Heat shock protein 90 protein levels were significantly reduced in the Cavin‐2 KO MEFs compared with the WT MEFs (0.69‐fold, P < 0.01). Conclusions Cavin‐2 loss suppressed fibroblast trans‐differentiation into myofibroblasts through the TGF‐β/Smad signalling. The loss of Cavin‐2 in cardiac fibroblasts suppresses cardiac fibrosis and may maintain cardiac function. |
| first_indexed | 2024-03-08T12:05:24Z |
| format | Article |
| id | doaj.art-1f696defc25a4617be70ccf2ee9d82dd |
| institution | Directory Open Access Journal |
| issn | 2055-5822 |
| language | English |
| last_indexed | 2024-03-08T12:05:24Z |
| publishDate | 2024-02-01 |
| publisher | Wiley |
| record_format | Article |
| series | ESC Heart Failure |
| spelling | doaj.art-1f696defc25a4617be70ccf2ee9d82dd2024-01-23T08:40:25ZengWileyESC Heart Failure2055-58222024-02-0111116717810.1002/ehf2.14571Cavin‐2 promotes fibroblast‐to‐myofibroblast trans‐differentiation and aggravates cardiac fibrosisYusuke Higuchi0Takehiro Ogata1Naohiko Nakanishi2Masahiro Nishi3Yumika Tsuji4Shinya Tomita5Simon J. Conway6Satoaki Matoba7Department of Cardiovascular Medicine, Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto JapanDepartment of Cardiovascular Medicine, Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto JapanDepartment of Cardiovascular Medicine, Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto JapanDepartment of Cardiovascular Medicine, Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto JapanDepartment of Cardiovascular Medicine, Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto JapanDepartment of Cardiovascular Medicine, Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto JapanHerman B. Wells Center for Pediatric Research, Department of Pediatrics Indiana University School of Medicine Indianapolis IN USADepartment of Cardiovascular Medicine, Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto JapanAbstract Aims Transforming growth factor β (TGF‐β) signalling is one of the critical pathways in fibroblast activation, and several drugs targeting the TGF‐β/Smad signalling pathway in heart failure with cardiac fibrosis are being tested in clinical trials. Some caveolins and cavins, which are components of caveolae on the plasma membrane, are known for their association with the regulation of TGF‐β signalling. Cavin‐2 is particularly abundant in fibroblasts; however, the detailed association between Cavin‐2 and cardiac fibrosis is still unclear. We tried to clarify the involvement and role of Cavin‐2 in fibroblasts and cardiac fibrosis. Methods and results To clarify the role of Cavin‐2 in cardiac fibrosis, we performed transverse aortic constriction (TAC) operations on four types of mice: wild‐type (WT), Cavin‐2 null (Cavin‐2 KO), Cavin‐2flox/flox, and activated fibroblast‐specific Cavin‐2 conditional knockout (Postn‐Cre/Cavin‐2flox/flox, Cavin‐2 cKO) mice. We collected mouse embryonic fibroblasts (MEFs) from WT and Cavin‐2 KO mice and investigated the effect of Cavin‐2 in fibroblast trans‐differentiation into myofibroblasts and associated TGF‐β signalling. Four weeks after TAC, cardiac fibrotic areas in both the Cavin‐2 KO and the Cavin‐2 cKO mice were significantly decreased compared with each control group (WT 8.04 ± 1.58% vs. Cavin‐2 KO 0.40 ± 0.03%, P < 0.01; Cavin‐2flox/flox, 7.19 ± 0.50% vs. Cavin‐2 cKO 0.88 ± 0.44%, P < 0.01). Fibrosis‐associated mRNA expression (Col1a1, Ctgf, and Col3) was significantly attenuated in the Cavin‐2 KO mice after TAC. α1 type I collagen deposition and non‐vascular αSMA‐positive cells (WT 43.5 ± 2.4% vs. Cavin‐2 KO 25.4 ± 3.2%, P < 0.01) were reduced in the heart of the Cavin‐2 cKO mice after TAC operation. The levels of αSMA protein (0.36‐fold, P < 0.05) and fibrosis‐associated mRNA expression (Col1a1, 0.69‐fold, P < 0.01; Ctgf, 0.27‐fold, P < 0.01; Col3, 0.60‐fold, P < 0.01) were decreased in the Cavin‐2 KO MEFs compared with the WT MEFs. On the other hand, αSMA protein levels were higher in the Cavin‐2 overexpressed MEFs compared with the control MEFs (2.40‐fold, P < 0.01). TGF‐β1‐induced Smad2 phosphorylation was attenuated in the Cavin‐2 KO MEFs compared with WT MEFs (0.60‐fold, P < 0.01). Heat shock protein 90 protein levels were significantly reduced in the Cavin‐2 KO MEFs compared with the WT MEFs (0.69‐fold, P < 0.01). Conclusions Cavin‐2 loss suppressed fibroblast trans‐differentiation into myofibroblasts through the TGF‐β/Smad signalling. The loss of Cavin‐2 in cardiac fibroblasts suppresses cardiac fibrosis and may maintain cardiac function.https://doi.org/10.1002/ehf2.14571Cardiac fibrosisCavin‐2FibroblastsTGF‐β/Smad signalling |
| spellingShingle | Yusuke Higuchi Takehiro Ogata Naohiko Nakanishi Masahiro Nishi Yumika Tsuji Shinya Tomita Simon J. Conway Satoaki Matoba Cavin‐2 promotes fibroblast‐to‐myofibroblast trans‐differentiation and aggravates cardiac fibrosis ESC Heart Failure Cardiac fibrosis Cavin‐2 Fibroblasts TGF‐β/Smad signalling |
| title | Cavin‐2 promotes fibroblast‐to‐myofibroblast trans‐differentiation and aggravates cardiac fibrosis |
| title_full | Cavin‐2 promotes fibroblast‐to‐myofibroblast trans‐differentiation and aggravates cardiac fibrosis |
| title_fullStr | Cavin‐2 promotes fibroblast‐to‐myofibroblast trans‐differentiation and aggravates cardiac fibrosis |
| title_full_unstemmed | Cavin‐2 promotes fibroblast‐to‐myofibroblast trans‐differentiation and aggravates cardiac fibrosis |
| title_short | Cavin‐2 promotes fibroblast‐to‐myofibroblast trans‐differentiation and aggravates cardiac fibrosis |
| title_sort | cavin 2 promotes fibroblast to myofibroblast trans differentiation and aggravates cardiac fibrosis |
| topic | Cardiac fibrosis Cavin‐2 Fibroblasts TGF‐β/Smad signalling |
| url | https://doi.org/10.1002/ehf2.14571 |
| work_keys_str_mv | AT yusukehiguchi cavin2promotesfibroblasttomyofibroblasttransdifferentiationandaggravatescardiacfibrosis AT takehiroogata cavin2promotesfibroblasttomyofibroblasttransdifferentiationandaggravatescardiacfibrosis AT naohikonakanishi cavin2promotesfibroblasttomyofibroblasttransdifferentiationandaggravatescardiacfibrosis AT masahironishi cavin2promotesfibroblasttomyofibroblasttransdifferentiationandaggravatescardiacfibrosis AT yumikatsuji cavin2promotesfibroblasttomyofibroblasttransdifferentiationandaggravatescardiacfibrosis AT shinyatomita cavin2promotesfibroblasttomyofibroblasttransdifferentiationandaggravatescardiacfibrosis AT simonjconway cavin2promotesfibroblasttomyofibroblasttransdifferentiationandaggravatescardiacfibrosis AT satoakimatoba cavin2promotesfibroblasttomyofibroblasttransdifferentiationandaggravatescardiacfibrosis |